Article thumbnail

The Role of TNF-α in Mice with Type 1- and 2- Diabetes

By Maria Koulmanda, Manoj Bhasin, Zuheir Awdeh, Andi Qipo, Zhigang Fan, Dusan Hanidziar, Prabhakar Putheti, Hang Shi, Eva Csizuadia, Towia A. Libermann and Terry B. Strom
Topics: Research Article
Publisher: Public Library of Science
OAI identifier:
Provided by: PubMed Central

Suggested articles


  1. (2005). A comprehensive review of interventions in the NOD mouse and implications for translation.
  2. (1985). An improved method for isolation of mouse pancreatic islets.
  3. (2006). Anti-CD3 and nasal proinsulin combination therapy enhances remission from recent-onset autoimmune diabetes by inducing Tregs.
  4. (2002). Anti-CD3 monoclonal antibody in new-onset type 1 diabetes mellitus.
  5. (2008). Curative and beta cell regenerative effects of alpha1-antitrypsin treatment in autoimmune diabetic NOD mice.
  6. (2004). Cure of overt diabetes in NOD mice by transient treatment with anti-lymphocyte serum and exendin-4.
  7. (2007). Dendritic cellexpanded, islet-specific CD4+ CD25+ CD62L+ regulatory T cells restore normoglycemia in diabetic NOD mice.
  8. (1994). Effect of tumor necrosis factor alpha on insulin-dependent diabetes mellitus in NOD mice. I. The early development of autoimmunity and the diabetogenic process.
  9. (2009). Etanercept treatment in children with new-onset type 1 diabetes: pilot randomized, placebocontrolled, double-blind study.
  10. (1988). Evidence for initial involvement of macrophage in development of insulitis in NOD mice.
  11. (1999). Exendin-4 stimulates both beta-cell replication and neogenesis, resulting in increased beta-cell mass and improved glucose tolerance in diabetic rats.
  12. (2005). Gene signatures of progression and metastasis in renal cell cancer.
  13. (2005). Insulin needs after CD3-antibody therapy in new-onset type 1 diabetes.
  14. (2011). Insulitis in human type 1 diabetes: The quest for an elusive lesion.
  15. (2003). Islet regeneration during the reversal of autoimmune diabetes in NOD mice.
  16. (2007). Modification of adverse inflammation is required to cure new-onset type 1 diabetic hosts.
  17. (2006). Nonobese diabetic mice express aspects of both type 1 and type 2 diabetes.
  18. (1990). Prevention of diabetes in nonobese diabetic mice by tumor necrosis factor (TNF): similarities between TNF-alpha and interleukin 1.
  19. (2006). RankProd: a bioconductor package for detecting differentially expressed genes in meta-analysis.
  20. (1994). Reduced tyrosine kinase activity of the insulin receptor in obesity-diabetes. Central role of tumor necrosis factor-alpha.
  21. (2008). Selective death of autoreactive T cells in human diabetes by TNF or TNF receptor 2 agonism.
  22. (2005). Simpleaffy: a BioConductor package for Affymetrix Quality Control and data analysis.
  23. (2003). TGF-betadependent mechanisms mediate restoration of self-tolerance induced by antibodies to CD3 in overt autoimmune diabetes.
  24. (2005). The NOD mouse: a model of immune dysregulation.
  25. (1990). Transfer of diabetes in mice prevented by blockade of adhesion-promoting receptor on macrophages.
  26. (2009). Translating molecular insights in autoimmunity into effective therapy.
  27. (1999). Tumor necrosis factor-alpha and the progression of diabetes in non-obese diabetic mice.

To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.